MULTIPLE SCLEROSIS

Adverse reaction reported in 46,709 FDA reports across 17 drugs.

46,709
Total Reports
17
Drugs Involved
Natalizumab
Most Reported Drug

Drugs Associated with MULTIPLE SCLEROSIS

Drugs where "MULTIPLE SCLEROSIS" was reported as an adverse event.

# Drug Reports % of Total
1 Natalizumab 9,733
20.8%
2 Interferon Beta-1a 9,333
20.0%
3 Dimethyl 5,723
12.3%
4 Dalfampridine 3,117
6.7%
5 Glatiramer 3,071
6.6%
6 Ocrelizumab 2,963
6.3%
7 Fingolimod 2,409
5.2%
8 Baclofen 2,323
5.0%
9 Teriflunomide 2,217
4.7%
10 Ofatumumab 1,439
3.1%
11 Interferon Beta-1b 1,167
2.5%
12 Diroximel 1,063
2.3%
13 Modafinil 686
1.5%
14 Peginterferon Beta-1a 558
1.2%
15 Siponimod 484
1.0%
16 Cladribine 249
0.5%
17 Ozanimod 174
0.4%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused multiple sclerosis. Always consult your healthcare provider.